Prosecution Insights
Last updated: November 04, 2026
Application No. 18/706,084

CURABLE RESIN COMPOSITION

Non-Final OA §102
Filed
Apr 30, 2024
Priority
Nov 08, 2021 — JP 2021-181702 +1 more
Examiner
BOYLE, ROBERT C
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Kyoeisha Chemical Co. Ltd.
OA Round
1 (Non-Final)
70%
Grant Probability
Favorable
1-2
OA Rounds
2m
Est. Remaining
67%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
798 granted / 1145 resolved
+4.7% vs TC avg
Minimal -3% lift
Without
With
+-2.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
32 currently pending
Career history
1181
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
43.4%
+3.4% vs TC avg
§102
19.5%
-20.5% vs TC avg
§112
25.9%
-14.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1145 resolved cases

Office Action

§102
DETAILED ACTION Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-3 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Morita (WO 2015/087920). As the WO document is not in English, citations are made to the attached translation. Morita teaches an example where a resin derived from ethylhexyl acrylate, hydroxypropyl acrylate, styrene, acrylic acid and isobutyl methacrylate (¶ 200-214, Table 1) is mixed with a catalyst of zinc octylate and 1-methylimidazole (¶ 203-205, Table 2-3, ¶ 219). 1-methylimidazole meets the formula of claim 3 when R1 is a methyl group, and R2-4 are hydrogen atoms. A resin derived from monomers such as ethylhexyl acrylate and isobutyl methacrylate have -COOR group where the R group is an alkyl group having 4 or 8 carbon atoms. The same resin contains monomeric units derived from hydroxypropyl acrylate which contain a hydroxyl group. Morita fails to explicitly state the catalyst is a transesterification catalyst. Case law holds that a recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. See MPEP 2111.02, In re Casey, 152 USPQ 235 (CCPA 1967) and In re Otto, 136 USPQ 458, 459 (CCPA 1963). In this case, the same zinc compound, zinc octylate, is present in the prior art as recited in the claim. Therefore, the zinc octylate of the prior art is capable of performing as a transesterification catalyst. Claim(s) 1-3 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Iwata (US 2014/0200305). Iwata teaches an example having a resin such as a copolymer derived from hydroxypropylacrylate and ethylhexyl acrylate (Table 1) which is used with the catalyst of zinc octylate and 1-methyl imidazole (¶ 152-153, Table 2). 1-methylimidazole meets the formula of claim 3 when R1 is a methyl group, and R2-4 are hydrogen atoms. A resin derived from monomers such as ethylhexyl acrylate and isobutyl methacrylate have -COOR group where the R group is an alkyl group having 4 or 8 carbon atoms. The same resin contains monomeric units derived from hydroxypropyl acrylate which contain a hydroxyl group. Morita fails to explicitly state the catalyst is a transesterification catalyst. Case law holds that a recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. See MPEP 2111.02, In re Casey, 152 USPQ 235 (CCPA 1967) and In re Otto, 136 USPQ 458, 459 (CCPA 1963). In this case, the same zinc compound, zinc octylate, is present in the prior art as recited in the claim. Therefore, the zinc octylate of the prior art is capable of performing as a transesterification catalyst. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROBERT C BOYLE whose telephone number is (571)270-7347. The examiner can normally be reached Monday-Thursday, 10am-4pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie (Lanee) Reuther can be reached at (571)270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROBERT C BOYLE/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Apr 30, 2024
Application Filed
Oct 28, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12774351
METHODS FOR CONVERTING PVC TO ELASTOMERS
2y 11m to grant Granted Oct 27, 2026
Patent 12767806
SEMICONDUCTIVE POLYPROPYLENE COMPOSITION
3y 4m to grant Granted Oct 20, 2026
Patent 12767818
AQUEOUS BIOPOLYMER DISPERSIONS
3y 3m to grant Granted Oct 20, 2026
Patent 12767759
METHOD FOR PREPARING POLYALKYLENE CARBONATE RESIN
3y 2m to grant Granted Oct 20, 2026
Patent 12760171
POLYETHYLENE OR POLYPROPYLENE ARTICLES
1y 6m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
70%
Grant Probability
67%
With Interview (-2.7%)
2y 8m (~2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1145 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month